Abstract
The effects of the human immunodeficiency virus type 1 envelope protein gp120 on the release of GABA elicited by N-methyl-D-aspartate (NMDA) from rat hippocampal neurons in primary culture has been investigated. NMDA (1–300 μM) increased in a concentration-dependent manner (EC50 = 37.9 ± 12 μM) the release of [3H]-GABA. The effect of 100 μM NMDA was prevented by 30 μM of the GABA transport inhibitor N-(4,4-diphenyl-3-butenyl)guvacine (SKF 100330A). Glycine (10 μM) or gp120 (0.01 μM) affected neither the basal nor the NMDA-evoked [3H]-GABA release. The NMDA (100 μM)-evoked release was prevented by 5,7-dichloro-kynurenic acid (5,7-DCKA), a selective antagonist at the glycine site of the NMDA receptor, in a concentration-dependent manner (IC50 ≃ 0.3 μM). Glycine (3–10 μM) or gp120 (0.003–0.01 μM) produced reversal of the 5,7-DCKA antagonism in a way that suggested competition at a same site; gp120 was at least 3 orders of magnitude more potent than glycine. It is suggested that gp120 may mimic glycine at NMDA receptors. J. Neurosci. Res. 49:732–738, 1997.

This publication has 22 references indexed in Scilit: